HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alfons Macaya Selected Research
Alfons Macaya Research Topics
Disease
17
Tuberous Sclerosis (Bourneville's Disease)
01/2022 - 06/2014
8
Migraine Disorders (Migraine)
01/2017 - 05/2009
7
Epilepsy (Aura)
10/2021 - 04/2016
6
Ataxia (Dyssynergia)
12/2018 - 01/2015
5
Neurodevelopmental Disorders
10/2021 - 01/2015
5
Seizures (Absence Seizure)
01/2021 - 08/2013
5
Rare Diseases (Rare Disease)
01/2021 - 11/2014
5
Angiomyolipoma
01/2020 - 04/2016
5
Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 04/2016
4
Cerebellar Diseases (Cerebellar Syndrome)
12/2018 - 10/2015
3
Migraine with Aura (Familial Hemiplegic Migraine)
02/2018 - 05/2009
3
Inborn Genetic Diseases (Disease, Hereditary)
01/2017 - 11/2014
2
Infantile Spasms (West Syndrome)
01/2021 - 03/2019
2
Neurologic Manifestations (Neurological Manifestations)
01/2021 - 06/2014
2
Neoplasms (Cancer)
01/2021 - 06/2014
2
Chorea (Rheumatic Chorea)
01/2020 - 01/2018
2
Leukoencephalopathies
01/2020 - 07/2006
2
Dystonia (Limb Dystonia)
01/2020 - 02/2006
2
Parkinsonian Disorders (Parkinsonism)
01/2020 - 01/2020
2
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
01/2019 - 01/2017
2
Muscle Hypotonia (Hypotonia)
01/2019 - 01/2019
2
Nervous System Diseases (Neurological Disorders)
11/2016 - 01/2015
2
Dyskinesias (Dyskinesia)
04/2016 - 01/2012
2
Atrophy
10/2015 - 01/2015
2
Migraine without Aura (Common Migraine)
09/2009 - 05/2009
1
Male Infertility (Male Sterility)
01/2022
1
Myoclonic dystonia
08/2021
1
Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
01/2021
1
Leigh Disease (Leigh's Disease)
01/2021
1
Megalencephaly
01/2021
1
Ischemic Stroke
07/2020
1
Hypertension (High Blood Pressure)
01/2020
1
Paraplegia (Spastic Paraplegia)
01/2020
1
Cerebellar Ataxia (Dysmetria)
01/2020
1
Frontotemporal Dementia (Semantic Dementia)
01/2020
1
Huntington Disease (Huntington's Disease)
01/2020
1
Hereditary Spastic Paraplegia
01/2020
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2020
1
Pallidopyramidal syndrome
01/2020
1
Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
05/2019
1
Muscle Weakness
05/2019
1
Headache (Headaches)
01/2019
1
Intellectual Disability (Idiocy)
01/2019
1
Dysarthria (Spastic Dysarthria)
12/2018
1
Channelopathies
02/2018
1
Stroke (Strokes)
02/2018
1
Hyperkinesis
01/2018
1
Angiofibroma
01/2017
1
Rhabdomyoma
01/2017
1
Type 2 Episodic Ataxia
01/2017
1
Episodic Ataxia
01/2017
1
Type 1 Episodic Ataxia
11/2016
1
Cognitive Dysfunction
04/2016
1
Movement Disorders (Movement Disorder)
04/2016
1
Infantile Epileptic-Dyskinetic Encephalopathy
04/2016
Drug/Important Bio-Agent (IBA)
18
trans-sodium crocetinate (crocetin)
IBA
01/2022 - 06/2014
4
phosphomannomutase
IBA
12/2018 - 10/2015
4
Congenital disorder of glycosylation type 1A
IBA
12/2018 - 10/2015
3
Everolimus
FDA Link
01/2022 - 04/2016
3
voltage-dependent calcium channel (P-Q type)
IBA
02/2018 - 01/2015
2
Steroids
IBA
01/2021 - 08/2013
2
Iron
IBA
01/2020 - 01/2020
2
MTOR Inhibitors
IBA
01/2019 - 04/2016
2
Calcium Channels (Calcium Channel)
IBA
01/2017 - 05/2014
2
GTP-Binding Proteins (G-Protein)
IBA
04/2016 - 07/2009
2
Amino Acids
FDA Link
01/2015 - 07/2009
2
Proteins (Proteins, Gene)
FDA Link
01/2010 - 05/2009
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
10/2021
1
Sarcoglycans (beta Sarcoglycan)
IBA
08/2021
1
P-2 (P 2)
IBA
01/2021
1
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
01/2021
1
Valine (L-Valine)
FDA Link
01/2021
1
Vigabatrin
FDA Link
01/2021
1
Complement System Proteins (Complement)
IBA
12/2020
1
TOR Serine-Threonine Kinases
IBA
01/2020
1
Levodopa (L Dopa)
FDA Link
Generic
01/2020
1
Quinidine (Chinidin)
FDA Link
Generic
12/2019
1
AMPA Receptors (AMPA Receptor)
IBA
12/2019
1
Cholinesterase Inhibitors (Anticholinesterases)
IBA
05/2019
1
Aminobutyrates (Aminobutyric Acid)
IBA
03/2019
1
gamma-Aminobutyric Acid (GABA)
IBA
03/2019
1
Vesicle-Associated Membrane Protein 2 (VAMP2)
IBA
01/2019
1
Nucleotides
IBA
01/2019
1
Caffeine (No Doz)
FDA Link
Generic
01/2019
1
lipoarabinomannan (LAM)
IBA
01/2019
1
3',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)
IBA
01/2018
1
Adenosine Monophosphate (AMP)
IBA
01/2018
1
Guanosine Monophosphate (5' Guanylic Acid)
IBA
01/2018
1
3' Untranslated Regions (3' UTR)
IBA
01/2017
1
Ion Channels (Ion Channel)
IBA
01/2017
1
Valproic Acid (Depakote)
FDA Link
Generic
01/2017
1
Topiramate (Topamax)
FDA Link
Generic
01/2017
1
Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)
IBA
11/2016
1
Sirolimus (Rapamycin)
FDA Link
04/2016
1
Glucuronidase
IBA
01/2016
Therapy/Procedure
4
Therapeutics
01/2021 - 04/2016
1
Treatment Delay
12/2020
1
Thrombectomy
07/2020
1
Nutritional Support (Artificial Feeding)
01/2019
1
Ketogenic Diet
04/2016